Use of frequency distribution curves, scattergrams and regression analyses to compare in vitro activities and describe cross-susceptibility and cross-resistance among four quinolonesFASS, R. J.Journal of chemotherapy. 1994, Vol 6, Num 6, pp 368-376, issn 1120-009XArticle

Erythromycin, clarithromycin, and azithromycin : use of frequency distribution curves, scattegrams, and regression analyses to compare in vitro activities and describe cross-resistanceFASS, R. J.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 10, pp 2080-2086, issn 0066-4804Article

In vitro activity of Bay y 3118, a new quinoloneFASS, R. J.Antimicrobial agents and chemotherapy. 1993, Vol 37, Num 11, pp 2348-2357, issn 0066-4804Article

Eficácia e segurança da ciprofloxacina oral no tratamento de infecções respiratórias graves = Efficacy and safety of oral ciprofloxacin in the treatment of serious respiratory infectionsFASS, R. J.Arquivos brasileiros de medicina. 1990, Vol 64, Num 2, pp 114-118, issn 0365-0723, 5 p.Article

In vitro activity of ciprofloxacin (Bay o 9867)FASS, R. J.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 4, pp 568-574, issn 0066-4804Article

Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilliFASS, R. J.Antimicrobial agents and chemotherapy. 1983, Vol 24, Num 2, pp 156-162, issn 0066-4804Article

Mudbanks of the southwest coast of India. III: Role of non-Newtonian flow properties in the generation and maintenance of mudbanksFASS, R. W.Journal of coastal research. 1995, Vol 11, Num 3, pp 911-917, issn 0749-0208Article

The quinolonesFASS, R. J.Annals of internal medicine. 1985, Vol 102, Num 3, pp 400-402, issn 0003-4819Article

In vitro activity of Bay 12-8039, a new 8-methoxyquinoloneFASS, R. J.Antimicrobial agents and chemotherapy. 1997, Vol 41, Num 8, pp 1818-1824, issn 0066-4804Article

In vitro activity of BAY v 3522, a new oral cephalosporinFASS, R. J.Antimicrobial agents and chemotherapy. 1990, Vol 34, Num 9, pp 1855-1857, issn 0066-4804, 3 p.Article

Comparative in vitro activities of third-generation cephalosporinsFASS, R. J.Archives of internal medicine (1960). 1983, Vol 143, Num 9, pp 1743-1745, issn 0003-9926Article

Aetiology and treatment of community-acquired pneumonia in adults : an historical perspectiveFASS, R. J.Journal of antimicrobial chemotherapy (Print). 1993, Vol 32, pp 17-27, issn 0305-7453, SUPAArticle

Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infectionsFASS, R. J.Antimicrobial agents and chemotherapy. 1987, Vol 31, Num 2, pp 148-150, issn 0066-4804Article

PHARMACOKINETICS OF SPECTINOMYCIN IN VOLUNTEERS WITH RENAL INSUFFICIENCYKUSUMI R; METZLER C; FASS R et al.1981; CHEMOTHERAPY (BASEL); ISSN 0009-3157; CHE; DA. 1981; VOL. 27; NO 2; PP. 95-98; BIBL. 9 REF.Article

Barrett's esophagus and other mucosal evidence of reflux in asymptomatic subjects with abnormal 24-hour esophageal pH monitoringFASS, R; SAMPLINER, R. E.Digestive diseases and sciences. 1994, Vol 39, Num 2, pp 423-425, issn 0163-2116Article

SILICATES AS NONSPECIFIC ADSORBENTS OF BACTERIOPHAGE: A MODEL FOR PURIFICATION OF WATTER FROM VIRUSESFASS R; STRAUSSMAN Y; SHAHAR A et al.1980; APPL. ENVIRONMENT. MICROBIOL.; USA; DA. 1980; VOL. 39; NO 1; PP. 227-232; BIBL. 16 REF.Article

Management of heartburn not responding to proton pump inhibitorsFASS, R; SIFRIM, D.Gut. 2009, Vol 58, Num 2, pp 295-309, issn 0017-5749, 15 p.Article

Extension of Squamous epithelium into the proximal stomach : A newly recognized mucosal abnormalityFASS, R; SAMPLINER, R. E.Endoscopy (Stuttgart). 2000, Vol 32, Num 1, pp 27-32, issn 0013-726XArticle

Partial regression of Barett's esophagus : an inadequate endpointSAMPLINER, R. E; FASS, R.The American journal of gastroenterology. 1993, Vol 88, Num 12, pp 2092-2094, issn 0002-9270Article

Functional heartburn: the stimulus, the pain, and the brainFASS, R; TOUGAS, G.Gut. 2002, Vol 51, Num 6, pp 885-892, issn 0017-5749, 8 p.Article

Clinical trial : acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburnDICKMAN, R; SCHIFF, E; HOLLAND, A et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 10, pp 1333-1344, issn 0269-2813, 12 p.Article

The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groupsSHAPIRO, M; GREEN, C; FAYBUSH, E. M et al.Alimentary pharmacology & therapeutics. 2006, Vol 23, Num 2, pp 321-329, issn 0269-2813, 9 p.Article

The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trialBAUTISTA, J; FULLERTON, H; BRISENO, M et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 10, pp 1123-1130, issn 0269-2813, 8 p.Article

Review article: approaches to endoscopic-negative reflux disease: part of the GERD spectrum or a unique acid-related disorder?TACK, J; FASS, R.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 19, Num 1, pp 28-34, issn 0953-0673, 7 p.Article

Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activitiesFASS, R; HELL, R; SAMPLINER, R. E et al.Digestive diseases and sciences. 1999, Vol 44, Num 11, pp 2263-2269, issn 0163-2116Article